A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
Abroad (travel likely)RecruitingPHASE1
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Neuroendocrine Carcinomas · Neuroendocrine Tumors · Carcinoma, Neuroendocrine · Carcinoma, Adrenocortical · Carcinoma, Adrenal Cortical
Locations
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States